NewYork-Presbyterian began offering the new Alzheimer’s disease medication lecanemab to patients in a hospital setting. Michael Toomey, 76, the hospital’s first patient, was accompanied to his appointment by his wife of 42 years, Wendy Sharp. They said it felt good to have this new option for treatment following his recent diagnosis of Alzheimer’s disease.
“It was hard getting that diagnosis, but in some ways, it was a relief,” Michael, a former graphic designer and art director, said as the infusion nurse prepared him for his first dose of lecanemab. “We didn’t know why I was having moments of losing or forgetting things. Once we got the diagnosis, we were able to make a plan. And that plan is to fight back against this disease as best we can.”
“We understand this won’t cure Alzheimer’s, but if it’s possible it will give us more time together, it’s worth it,” added Wendy.